Aromatase inhibitors in male breast cancer: a pooled analysis.

about

Male Breast Cancer: A Study in Small Steps Male breast cancer - a single center experience.Male Breast Cancer: Pink Ribbon Blues.Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer.

P2860

Q36064861-0D77B210-68F8-4B3B-B5DE-1A9587C2264A Q37107330-B2789A28-BE0E-41AB-9C76-0A48D6271752 Q49813617-F3475EED-35D4-4E56-88A5-01FA9BEE47B1 Q54597474-2859CDB9-4FB8-48A6-9CD7-384B9F102D66

P2860

Aromatase inhibitors in male breast cancer: a pooled analysis.

Item

http://www.wikidata.org/entity/Q41104737

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Aromatase inhibitors in male breast cancer: a pooled analysis.

@en

type

Item

label

Aromatase inhibitors in male breast cancer: a pooled analysis.

@en

prefLabel

Aromatase inhibitors in male breast cancer: a pooled analysis.

@en

P1476

Aromatase inhibitors in male breast cancer: a pooled analysis.

@en

P2093

Dimosthenis Chrysikos

http://www.w3.org/2001/XMLSchema#string

Flora Zagouri

http://www.w3.org/2001/XMLSchema#string

Hatem A Azim

http://www.w3.org/2001/XMLSchema#string

Theodora Psaltopoulou

http://www.w3.org/2001/XMLSchema#string

Theodoros N Sergentanis

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival.

Bilateral Nonsynchronous Male Breast Cancer: Two Case Reports.

Prospective evaluation of risk factors for male breast cancer

Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Male breast cancer: an update in diagnosis, treatment and molecular profiling

P2888

s10549-015-3356-9

P304

141-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S10549-015-3356-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

Meletios A. Dimopoulos

P577

2015-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274729551

http://www.w3.org/2001/XMLSchema#string

P6179

1012582531

http://www.w3.org/2001/XMLSchema#string

P698

25850534

http://www.w3.org/2001/XMLSchema#string

Aromatase inhibitors in male breast cancer: a pooled analysis.

about

P2860

P2860

Aromatase inhibitors in male breast cancer: a pooled analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698